-
Gilead Sciences Breaks Out To Record Highs, The Rally Has Room To Run
19 Oct 2025 04:57 GMT
Gilead Sciences (GILD) is a top-performing … GILD, citing solid fundamentals, positive earnings momentum, and sector-leading technical … Q3 earnings.
Sundry Photography/iStock Editorial via Getty Images Gilead Sciences (NASDAQ …
-
US close: Dow Jones retreats from record highs as US-China tensions flare
22 Oct 2025 22:36 GMT
… while Netflix's quarterly earnings missed Wall Street estimates due … Q3 group revenues and adjusted profits came in ahead of … , but also revealed quarerly earnings had fallen short of estimates … ) $2,093.06 -2.29%
Gilead Sciences Inc. (GILD) $121.46 - …
-
Generic Lenacapavir Could Help End HIV Epidemic by 2030
22 Oct 2025 12:15 GMT
… currently manufactured and marketed by Gilead Sciences, Inc.
“Lenacapavir is the … overfill in vials, a 30% profit margin for generic suppliers, … price and still make large profits,” he said. That price … something that is still profitable for Gilead but not …
-
Nurix Therapeutics Announces $250.0 Million Registered Offering of Common Stock
22 Oct 2025 11:20 GMT
… programs under collaboration agreements with Gilead Sciences, Inc., Sanofi S.A. and … co-development, co-commercialization and profit sharing in the United States …
-
Nurix Initiates DAYBreak™ Pivotal Study of Bexobrutideg in Relapsed or Refractory Chronic Lymphocytic Leukemia
22 Oct 2025 10:00 GMT
… programs under collaboration agreements with Gilead Sciences, Inc., Sanofi S.A. and … co-development, co-commercialization and profit sharing in the United States …
-
Galapagos to Wind Down Cell Therapy Business After Search for a Buyer Comes Up Empty
22 Oct 2025 01:16 GMT
… that legacy Galapagos had with Gilead Sciences. Gilead retains an equity stake … moves by AstraZeneca, AbbVie, and Gilead Sciences. Each of those deals brings … company’s third-quarter 2025 earnings report in early November.
Photo …
-
Galapagos to wind down cell therapy business after failed attempt at sale
21 Oct 2025 17:13 GMT
… and a lucrative partnership with Gilead Sciences. After an initial research collaboration … when it reports third-quarter earnings in early November.
-
AHF: 80 Organizations Denounce Gilead on Price Hikes Gutting ADAP
21 Oct 2025 10:58 GMT
… by over 80 organizations to Gilead Sciences denouncing the company’s plan … has ruthlessly sought to boost profits by restricting access to Gilead … has had one goal – maximizing profits of the older drugs in …
-
Goldman Sachs Reveals Sectors With Top 2026 Payouts: 5 Strong Buys
21 Oct 2025 00:34 GMT
… growth as a function of earnings growth in the same year … a good time to take profits on high-flying tech stocks … at 14.5 times forward earnings and paying a 2. … Bayer, Eisai, Ridgeback Biotherapeutics, and Gilead Sciences to jointly develop and commercialize …
-
IDWeek: Generic lenacapavir could cost as little as $25 per person annually
20 Oct 2025 21:18 GMT
… for formulation, labor, a 30% profit margin, and 27% taxation.1 … prioritize both equitable access and profits in tandem and realize the … HIV epidemic.”
“Lenacapavir’s manufacturer, Gilead Sciences, has discovered and brought a …
About
© 1995-2025